These are my top 3 defensive shares to buy in 2025!

Mark Hartley considers three shares he feels could provide stability if markets are volatile — and if he wants to buy more for his portfolio.

| More on:
Number three written on white chat bubble on blue background

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

When considering which shares to buy in 2025, I’ve become increasingly concerned about the uncertainty ahead. From interest rate fluctuations in Europe to trade tariff threats in the US, markets look set for a rocky year.

Sure, when the economy is strong, it can pay to consider riskier growth stocks. But as a risk-averse investor, the current environment has drawn me to consider the benefits of defensive stocks. With slow growth, these stocks may appear less attractive but are usually more stable. I’m thinking consumer goods, healthcare, and utility stocks as they remain in demand even when the economy falters.

With that in mind, I think the following stocks are worth considering. I already own them and plan to buy more as the year progresses.

Consumer Goods

British American Tobacco (LSE: BATS) has experienced volatility of only 1.09% over the past month. It’s also a solid and reliable dividend giant and a top 10 constituent of the FTSE UK High Dividend Low Volatility Index (as of December 2024).

Its yield looks high at 8% but, unlike some others, this isn’t due to a falling price. In fact, the stock is up 26% in the past year. What’s more, its dividends have been increasing consistently for over 20 years. 

However, it’s fair to say that tobacco is controversial and might face a questionable future. Although it’s working hard to transition to less harmful smoke-free products, there’s no guarantee this strategy will work. Increasingly strict regulations could derail its progress.

Based on future cash flow estimates, it’s trading at 54% below fair value with the average 12-month forecast targeting a 9.7% price increase.

Utilities 

National Grid (LSE: NG.) is another solid dividend stock with low volatility. As the core supplier of gas and electricity to the UK, it’s well positioned to maintain steady revenue. 

The stock has weathered previous market dips relatively well. Over the past two decades, it’s up 158% — an annualised growth of 4.85% per year. It also has a 5.4% yield and experienced only 1.33% volatility over the past month.

Yet it does face challenges. Balancing the need to supply low-cost energy while meeting carbon-reduction goals has proven difficult, pushing it into debt. It needs to find a way to balance these requirements without risking losses.

Earnings are expected to fall to 71p per share in the next full-year results. Despite this, the average 12-month price target envisions a 23.4% rise.

Healthcare

AstraZeneca (LSE: AZN) is one of the most well established UK healthcare companies.

It’s slightly more volatile than others, at 1.48% in the past month. During Covid, it experienced unusually high growth and has since gone through several corrective periods. If faces risks from an ongoing government probe in China and clinical trial setbacks that could threaten profits.

Historically, long-term price growth has been good, increasing at an annual rate of 7.4% since 2005. It’s also a reliable dividend payer although the yield is currently low, at only 2%.

Analysts expect earnings to rise to £6.59 per share in the next full-year results, up from £5.70 in 2003. The average 12-month forecast predicts a 28% increase in price, with the most bearish analyst expecting only a 0.42% loss.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Mark Hartley has positions in AstraZeneca Plc, British American Tobacco P.l.c., and National Grid Plc. The Motley Fool UK has recommended AstraZeneca Plc, British American Tobacco P.l.c., and National Grid Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

2 UK shares that could soar if interest rates sprint lower!

The Bank of England's latest meeting has fed speculation of swingeing interest rate cuts. I think these UK shares could…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

My favourite FTSE dividend stock just jumped 17%! So why am I sad?

This investor has mixed feelings today as a quality dividend stock from the FTSE 250 surged higher in his portfolio.…

Read more »

Investing Articles

Here’s why AstraZeneca stock jumped nearly 6% in the FTSE 100 today

FTSE 100 heavyweight AstraZeneca helped propel the blue-chip index to a record high today. Here's what investors were cheering.

Read more »

Closeup of "interest rates" text in a newspaper
Investing Articles

Interest rates fall again! Here are 3 FTSE dividend growth shares to consider buying

As interest on cash savings becomes increasingly less attractive, Paul Summers has been looking at dividend growth shares for passive…

Read more »

Investing Articles

Up 10% today, I think this FTSE 250 growth share could continue to surge!

Babcock International's flying after upgrading its full-year forecasts. I think the FTSE 250 defence share might just be getting started.

Read more »

Investing Articles

The AstraZeneca share price jumps 5% on today’s strong results – but is it too expensive?

Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's biggest company…

Read more »

Investing Articles

Is this my chance to buy Alphabet shares?

A big step up in AI spending at Google has investors nervous, but has it created an opportunity to buy…

Read more »

Senior woman potting plant in garden at home
Investing Articles

£10k in savings? Here’s how an investor could aim for a monthly second income of £1,200

Mark David Hartley considers how investors could build towards an early retirement plan with a second income from a portfolio…

Read more »